Dermatology Flashcards

1
Q

Cutaneous adverse drug reactions

A
  • Antibiotics maculopapular erythematous
    • Erythema= flushing
    • Morbilliform= measles like
    • Maculo= distinct flat areas
    • Papular= raised lesions
    • Urticaria (nettle rash)
  • Erythema multiforme (Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening)
  • Sulphonamides, allopurinol, meloxicam, piroxicam, CBZ, lamotrigine, phenytoin and phenobarbitone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Penicillin allergy

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cutaneous adverse drug reactions

A
  • Fixed drug eruptions- flat and purple-brown
    • Usually only 1 lesion on first exposure. If repeated lesion re-occurs in the same place. Possible only ADR where rechallenge is safe
  • Systemic lupus erythematosus (SLE) butterfly rash on face
  • Acneform- androgens in women
  • Photosensitivity- doxycycline, phenothiazines
  • Hair disorders- anticonvulsants- alopecia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Fixed drug eruption

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Redman syndrome- vancomycin

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acne vulgaris

A
  • Chronic inflammatory disorder of the sebaceous glands
  • Common- affects 80% of the population between 11-30 years
  • The increasing resurgence in women in 4th & 5th decade
  • Often confined to face (99%), but also back (60%) and chest (15%)
  • Concern- can lead to scarring
  • Acne effects chest and back rosacea doesn’t important to distinguish between the two
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acne- aetiology

A
  • Increased sebum production (Often related to puberty)
  • Obstruction of the pilosebaceous cyst (comedone)
  • The colonisation of the anaerobe Propionibacterium acnes
  • Inflammation
  • MILD- comedones closed (whiteheads), open (Blackheads)
  • MODERATE- open and closed comedones, papules and pustules
  • SEVERE- papules, pustules, nodules and cysts
  • Can lead to scarring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Scarring

A

*

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

treatment of acne

A
  • Self-help
  • Tropical agents- benzoyl peroxide (essentially peels skin exposes anaerobic bacteria to air = they die) it is very important to gradually increase time you have this on skin for start at 2 minutes and increase to 30 and place on entire area you get spots not just the spot itself, azelaic acid, retinoids, antibiotics
  • Comedones- retinoid first
  • Inflammatory- benzoyl peroxide first
  • Moderate and likely to scar: Oral antibiotics (Tetracyclines/Macrolides) & topical BPO or retinoid
  • Cyproterone acetate + ethinylestradiol
  • Oral isotretinoin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Oral isotretinoin- consultant dermatologist

A
  • Teratogenicity- a pregnancy test must be negative up to three days before treatment, every month during treatment and for five weeks after stopping. Treatment should be started on day 2-3 of the menstrual cycle. Barrier methods should not be used alone and progestogen-only contraceptives are not sufficiently effective
  • Prescription- Only 30 days may be prescribed at a time. It can’t be faxed and is only valid for seven days. Course- up to 16 weeks
  • Avoid exposure to UV light. Use high factor sunscreen and lip salve from the start of treatment
  • Can increase both triglycerides, increasing the risk of pancreatitis and ChE, with lowering HDL
  • May raise liver transaminase, avoid in hepatic impairment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acne vulgaris- skin care tips

A
  • Wash face BD with mild cleanser/antibacterial face wash with lukewarm water, pat dry
  • Don’t scrub face or use facial scrubs
  • Use light oil-free/ non-comedogenic moisturiser
  • When applying topical acne treatment- apply thin film to whole area not just individual spots- washing hands before and after applying
  • Make up- use non-comedogenic
  • Shaving- wash face in acne wash before- use light moisturiser as a shaving lotion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rosacea

A
  • Latin for roses
  • Spectrum of facial skin and vascular changes, characterised by
    • Flushing- Erythema
    • Burning/Tingling sensation
    • Telangiectasia
    • Skin papules/Lesions
    • Rhinophyma
  • Central face- usually spares the peri-oral/ peri-orbital area
  • Can be continuous or variable flushing episodes
  • Avoids folds of the nose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

rosacea

A
  • Typically presents from 30-60s most common 40s and 50s
  • More common in women than men
  • Rhinophyma more common in men
  • More common in Caucasians, rare in Asians and Africans
  • Prevalence about 12%
  • Cause uncertain- damage to dermal connective tissue, linked to migraine, susceptibility to Demodex mite
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Rosacea- 4 types

A
  • Erythemato-terlangiecatctic- redness of the central face (Transient or permanent) affected skin feels rough, sometimes telangiectasia, may tingle/burn
  • Papulo-pustular- Acne vulgaris, Papules and pustules mainly over cheecks and nose (also forehead, chin and around eyes)
  • Phymatous- Lump/swelling, usually of nose (commoner in men)
  • Ocular- co-ecists with rosacea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Seborrhoeic dermatitis

A
  • Nasolabial folds
  • Eyebrows, hairline, behind ears; also scalp and upper trunk
  • Scaly patches, greasy appearance, rather than discreet lesions
  • Yeast- treat with antifungal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment of rosacea

A
  • Sunscreen- 30 SPF
  • Avoidance of irritants and other triggers
  • Avoid topical steroids- aggravate rosacea
  • Camouflage
  • Topical
  • Systemic
  • Laser therapy (Persistent erythema)
  • Surgical debulking (Rhinophyma)
18
Q

Erythematous-telangiectatic- treatment

A
  • Topical
    • Brimonidine tartrate 3mg/g
    • Reduces erythema by cutaneous vasoconstriction
  • Systemic
    • Non-cardioselective BB propranolol 40mg BD or clonidine 50mcg BD
19
Q

Papular-pustular treatment

A
  • Topical
    • Ivermectin 10mg/g cream
    • Inhibits inflammatory cytokines, control demodex mites
    • Metronidazole 0.75% gel
    • Azelaic acid 15% gel
  • Systematic
    • Oxytetracycline 500mg BD, lymecycline 408mg OD
    • OR doxycycline 40mg OD, erythromycin 500mg BD
20
Q

Ocular rosacea treatment

A
  • Lid hygiene and artificial tears
  • Oral tetracyclines
  • Refer to ophthalmology
21
Q

Rosacea- skin care tips

A
  • Emollients
  • Avoid overheating, keep rooms cool, avoid hot showers/baths
  • Reduce facial redness for short periods by holding an ice block in moth, between the gum + cheek
  • Limit alcohol intake
  • Avoid hot, spicy foods
  • Avoid washing with soap, astringent. cleansers and wipes
  • Wash face with emollient wash
  • Avoid oil-based skin products
  • Use light, non-greasy moisturisers to soothe stinging and burning
  • Protect face all year round with SPF 30 sun cream
22
Q

Eczema

A
  • Dermatitis- interchangeable term
  • Inflammatory condition of the epidermis
  • In UK, affects 20% of children and 8% of adults
  • Atopic eczema has a strong genetic component, FH of dermatitis, hayfever or asthma
23
Q

Other types

A
  • Irritant contact dermatitis
  • Allergic contact dermatitis
  • Discoid eczema
  • Seborrhoeic dermatitis
  • Venous eczema
  • Otitis externa
24
Q

Scoring systems

A
  • EASI (Eczema Area and Severity Index)
  • DLQI (Dermatology life quality index)
25
Treatment of atopic eczema
* Self-help (Warm water, pat dry, avoid soap, cotton avoid irritants) * Emollients * Topical corticosteroids * Topical immunomodulators * Oral systemic * Biology
26
Emmollients
* Cornerstone of management • Apply liberally • Apply often • Differentformulationsfordifferentareas • Givepatientschoice * How to apply * CARE – make fabrics flammable
27
Topical corticosteroids
* Potency * USE OD * 10-15 minutes after emollient * Finger-tip units * Used for flares * Maintenance * Side effect concerns
28
Other topicals
* Bandages- ichthammol and zinc oxide, or coal tar * Dry-wrap dressings * Pimecrolimus * Tacrolimus * Phototherapy
29
Systematic treatments
* Antibiotics * Antihistamines * Systematic steroids- short course * Licensed- ciclosporin * Unlicensed- MTX, azathioprine, mycophenolate * Biological- dupilumab- mAb, blocks signalling from IL-4 and 13
30
Hand eczema
* Emollients * Topical steroids * Alitretinoin * PUVA * Systemic immuno-suppressants
31
Psoriasis
* Chronic Immune-Mediated Inflammatory Disease (IMID) * Systemic disorder * UK prevalence 1.3-2.2% * Usually develops before the age of 50, uncommon in children * Strong genetic component, multifactorial
32
Psoriasis- a systematic disorder
* Psoriatic arthritis- 25%-34% * Obesity * Metabolic syndrome * Atherosclerotic vascular disease * Infalmmatory bowel disease * Malignancy * Depression
33
Chronic plaque psoriasis
* Most common form (90%) * Scaling and epidermal thickening * Red, clearly defined borders and salivery scales * Lesions usually symmetrical * Typically scalp, extensor surfaces such as elbows, knees, buttocks and lower back
34
Other types
* **Scalp** * **Palmoplantar** * **Guttate-** small, red separate spots on the skin usually after streptococcal infection * **Flexural-** submammary, groin, axillary, genital and natal cleft * **Pustular-** sudden breakout of pus-filled blisters * **Erythrodermic-** widespread erythroderma in people in pre-existing or unstable psoriasis
35
Nail changes
* Occur in 50% of patients * More common in patients with psoriatic arthritis * Difficult to treat
36
Scoring systems
* BSA * PASI (Psoriasis Area and Severity Index) * DLQI (Dermatology Life Quality Index) * PEST (Psoriasis Epidemiological Screening Tool)
37
Systematic treatment- oral/non-biologicals
* MTX * Acitretin- retinoid * Ciclosporin- inhibits release of lymphokines * Apremilast- Phosphodiesterase Type-4 inhibitor * Dimethyl fumarate- immunomodulator
38
Systemic treatment- biologicals
* Etanercept- TNF a-inhibitor * Infliximab- TNF a-inhibitor * Adalimumab- TNF a-inhibitor * Secukinumab0 Interleukin inhibitor, IL-17A * Usekinumab- mAb, Interleukin inhibitor, IL-2 and 23
39
Melanoma- Glasgow 7 point checklist
* **Major features** * Changes in size * Irregular shape * Irregular colour * **Minor features** * Diameter \>7mm * Inflammation * Oozing * Change in sensation
40
The ABCDEs of melanoma
* A-symmetry * B-order irregularity * C-olour variation * D-iameter over 6mm * E-volving (enlarging, changing)
41